ATR: Strategic focus on pharma, innovation, and patient-centric solutions drives growth and margin strength
Leadership is focused on delivering 2026 commitments and long-term growth, with the Pharma segment as a key driver. Innovation, pipeline expansion, and a diversified revenue model support robust margins and growth, while a strong balance sheet enables continued investment and shareholder returns.Ba…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.